105635-75-4 Usage
Description
Ethocyn is a proprietary chemical compound developed by Chantal Pharmaceuticals, specifically designed to stimulate the production of elastin, a protein crucial for maintaining skin elasticity and firmness. As the production of elastin declines with age, leading to wrinkles and sagging, Ethocyn targets specific enzymes in the skin to enhance elastin production, thereby improving skin firmness and texture. It is widely incorporated into anti-aging skincare products and has demonstrated effectiveness in reducing the appearance of wrinkles and fine lines. However, ongoing research is still required to fully understand and assess the long-term effects and safety of this compound.
Uses
Used in Anti-Aging Skincare Industry:
Ethocyn is used as an active ingredient in anti-aging skincare products for its ability to increase elastin production, which helps improve skin firmness and texture. This contributes to a reduction in the appearance of wrinkles and fine lines, providing a more youthful appearance to the skin.
Used in Cosmetic Formulations:
Ethocyn is used as a key component in cosmetic formulations to address the signs of aging. Its role in enhancing elastin production makes it a valuable asset in the development of products aimed at improving skin elasticity and reducing the visible effects of aging, such as wrinkles and sagging.
Check Digit Verification of cas no
The CAS Registry Mumber 105635-75-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,6,3 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 105635-75:
(8*1)+(7*0)+(6*5)+(5*6)+(4*3)+(3*5)+(2*7)+(1*5)=114
114 % 10 = 4
So 105635-75-4 is a valid CAS Registry Number.
105635-75-4Relevant articles and documents
METHOD OF SYNTHESIS
-
, (2014/09/29)
Described is a method of synthesizing 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0] octan-3-one by reacting 3-(5-ethoxyhept-1-yl) cyclopentene with dichloroketene. The resulting reaction products are reacted with acetic acid and zinc to produce 4-(5-ethoxyhept-1 -yl)bicyclo[3.2.0]heptan-6-one and 4-(5-ethoxyhept-1-yl)bicyclo [3.2.0]heptan-7-one, which are reacted with trimethylsulfonium iodide to produce 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2'-oxirane]. Lithium iodide is reacted with 2-(5-ethoxyhept-1-yl)spiro[bicyclo[3.2.0]heptane-6,2'-oxirane] and 4-(5-ethoxyhept-1-yl)spiro-[bicyclo-[3.2.0]heptane-6,2'-oxirane] to produce 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one. A method of synthesizing 6-(5-methoxyhept-1-yl)bicyclo[3.3.0]octan-3-one is also described.
